
Sign up to save your podcasts
Or


Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.
By John Simboli5
77 ratings
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.

3,067 Listeners

1,942 Listeners

1,093 Listeners

2,363 Listeners

945 Listeners

796 Listeners

124 Listeners

321 Listeners

6,074 Listeners

94 Listeners

9,986 Listeners

523 Listeners

146 Listeners

249 Listeners

180 Listeners